Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomasJustin Z. Wang, Gelareh Zadeh|Acta Neuropathologica|2023Cited by 48
Liquid Biomarkers for Improved Diagnosis and Classification of CNS TumorsSevera Bunda, Gelareh Zadeh, Farshad Nassiri et al.|International Journal of Molecular Sciences|2021Cited by 38
Fractionated radiotherapy for surgically resected intracranial meningiomas: A multicentre retrospective cohort studyJustin Z. Wang, Gelareh Zadeh, Farshad Nassiri et al.|Radiotherapy and Oncology|2023Cited by 14
Surgery for Recurrent Glioblastoma Multiforme: A Retrospective Case Control StudyMathew Voisin, Gelareh Zadeh, Jeffrey Zuccato et al.|World Neurosurgery|2022Cited by 11
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomasJustin Z. Wang, Gelareh Zadeh|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 8